Volume 17, Issue 1

Neurotherapeutics is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.

Search all Neurotherapeutics articles

January 2020

Translational Research in the Neurobiological Mechanisms of Alcohol and Substance Use Disorders

31 articles in this issue

Translational Research in the Neurobiological Mechanisms of Alcohol and Substance Use Disorders
Carolina L. Haass-Koffler
Jesse R. Schank
Editorial 21 January 2020 Pages: 1 - 3
Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder
Kana Hamada
Amy W. Lasek
Review 15 October 2019 Pages: 4 - 16
GPCR and Alcohol-Related Behaviors in Genetically Modified Mice
Jérémie Neasta
Emmanuel Darcq
Sami Ben Hamida
Review 09 January 2020 Pages: 17 - 42
Considering Drug-Associated Contexts in Substance Use Disorders and Treatment Development
Mandy Rita LeCocq
Patrick A. Randall
Nadia Chaudhri
Review 02 January 2020 Pages: 43 - 54
Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
Amanda J. Abraham
Christina M. Andrews
Peter D. Friedmann
Review 06 January 2020 Pages: 55 - 69
Alcohol Use Disorder Interventions Targeting Brain Sites for Both Conditioned Reward and Delayed Gratification
Brandon G. Oberlin
Yitong I. Shen
David A. Kareken
Review 20 December 2019 Pages: 70 - 86
Assessing Cannabis Demand: A Comprehensive Review of the Marijuana Purchase Task
Elizabeth R. Aston
Lidia Z. Meshesha
Review 08 January 2020 Pages: 87 - 99
Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations
Kimberly Goodyear
Carolina L. Haass-Koffler
Review 24 October 2019 Pages: 100 - 104
Intranasal Insulin: a Treatment Strategy for Addiction
Bhavani Kashyap
Leah R. Hanson
William H. Frey II
Review 02 January 2020 Pages: 105 - 115
Non-invasive Brain Stimulation for Alcohol Use Disorders: State of the Art and Future Directions
Noah S. Philip
David O. Sorensen
Colleen A. Hanlon
Review 26 August 2019 Pages: 116 - 126
Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows
Giovanni Addolorato
Gabriele A. Vassallo
Antonio Gasbarrini
Review 11 November 2019 Pages: 127 - 141
The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials
Stephen M. Chrzanowski
Basil T. Darras
Seward B. Rutkove
Current Perspectives 26 December 2019 Pages: 142 - 152
The Long and the Short of Benzodiazepines and Sleep Medications: Short-Term Benefits, Long-Term Harms?
Steven T. DeKosky
John B. Williamson
Commentary 06 January 2020 Pages: 153 - 155
Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use
Li-Yen Tseng
Shih-Tsung Huang
Fei-Yuan Hsiao
Original Article 04 December 2019 Pages: 156 - 164
Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naïve and Cocaine-Exposed Mice
Elizabeth G. Pitts
Elizabeth T. Barfield
Shannon L. Gourley
Original Article 19 June 2019 Pages: 165 - 177
Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer’s Mouse Model
Tian Wang
Jia Yao
Roberta Diaz Brinton
Original Article 29 October 2019 Pages: 178 - 188
Picrorhiza kurroa Prevents Memory Deficits by Inhibiting NLRP3 Inflammasome Activation and BACE1 Expression in 5xFAD Mice
Namkwon Kim
Jimin Do
Myung Sook Oh
Original Article 18 November 2019 Pages: 189 - 199
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
Marinella Clerico
Stefania Federica De Mercanti
Ruggero Capra
Original Article 26 August 2019 Pages: 200 - 207
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis
Paolo Preziosa
Maria A. Rocca
Massimo Filippi
Original Article 26 August 2019 Pages: 208 - 217
Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
Karen Henriette Pinke
Sofia Fernanda Gonçalves Zorzella-Pezavento
Alexandrina Sartori
Original Article 28 August 2019 Pages: 218 - 234
Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice
Maria M. Dimitriadou
Haris Alexopoulos
Marinos C. Dalakas
Original Article 31 October 2019 Pages: 235 - 242
Brain Zinc Deficiency Exacerbates Cognitive Decline in the R6/1 Model of Huntington’s Disease
Scott Ayton
Peng Lei
Ashley I. Bush
Original Article 13 September 2019 Pages: 243 - 251
Vildagliptin Attenuates Huntington’s Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
Noha H. Sayed
Nevine Fathy
Ahmed S. Kamel
Original Article 14 November 2019 Pages: 252 - 268
Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
Pascual Torres
Daniel Cacabelos
Victòria Ayala
Original Article 21 November 2019 Pages: 269 - 281
Early and Sustained Increases in Leukotriene B₄ Levels Are Associated with Poor Clinical Outcome in Ischemic Stroke Patients
Su Jing Chan
Mary P. E. Ng
Raymond C. S. Seet
Original Article Open access 13 September 2019 Pages: 282 - 293
Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats
Weilin Xu
Jun Mo
John H. Zhang
Original Article 29 August 2019 Pages: 294 - 308
N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug
Krzysztof Kamiński
Katarzyna Socała
Piotr Wlaź
Original Article Open access 04 September 2019 Pages: 309 - 328
Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia
Viera Kútna
Libor Uttl
Saak V. Ovsepian
Original Article 09 December 2019 Pages: 329 - 339
Levo-corydalmine Attenuates Vincristine-Induced Neuropathic Pain in Mice by Upregulating the Nrf2/HO-1/CO Pathway to Inhibit Connexin 43 Expression
Lin Zhou
Luyao Ao
Yunman Li
Original Article 15 October 2019 Pages: 340 - 355
Fabrication and Evaluation of a Xenogeneic Decellularized Nerve-Derived Material: Preclinical Studies of a New Strategy for Nerve Repair
Ting Li
Zhigang Sui
Qiang Ao
Original Article 22 November 2019 Pages: 356 - 370
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
Mohd Nasir Mat Nor
Ilva D. Rupenthal
Monica L. Acosta
Original Article 21 October 2019 Pages: 371 - 387

Volume 17, Issue 1

Translational Research in the Neurobiological Mechanisms of Alcohol and Substance Use Disorders

Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder

GPCR and Alcohol-Related Behaviors in Genetically Modified Mice

Considering Drug-Associated Contexts in Substance Use Disorders and Treatment Development

Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA

Alcohol Use Disorder Interventions Targeting Brain Sites for Both Conditioned Reward and Delayed Gratification

Assessing Cannabis Demand: A Comprehensive Review of the Marijuana Purchase Task

Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations

Intranasal Insulin: a Treatment Strategy for Addiction

Non-invasive Brain Stimulation for Alcohol Use Disorders: State of the Art and Future Directions

Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows

The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials

The Long and the Short of Benzodiazepines and Sleep Medications: Short-Term Benefits, Long-Term Harms?

Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use

Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naïve and Cocaine-Exposed Mice

Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer’s Mouse Model

Picrorhiza kurroa Prevents Memory Deficits by Inhibiting NLRP3 Inflammasome Activation and BACE1 Expression in 5xFAD Mice

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis

Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?

Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice

Brain Zinc Deficiency Exacerbates Cognitive Decline in the R6/1 Model of Huntington’s Disease

Vildagliptin Attenuates Huntington’s Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model

Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice

Early and Sustained Increases in Leukotriene B₄ Levels Are Associated with Poor Clinical Outcome in Ischemic Stroke Patients

Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats

N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug

Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia

Levo-corydalmine Attenuates Vincristine-Induced Neuropathic Pain in Mice by Upregulating the Nrf2/HO-1/CO Pathway to Inhibit Connexin 43 Expression

Fabrication and Evaluation of a Xenogeneic Decellularized Nerve-Derived Material: Preclinical Studies of a New Strategy for Nerve Repair

Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease

Navigation